A detailed history of Wealth Collab, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wealth Collab, LLC holds 220 shares of ABBV stock, worth $36,297. This represents 0.03% of its overall portfolio holdings.

Number of Shares
220
Previous 246 10.57%
Holding current value
$36,297
Previous $42.2 Million 2.96%
% of portfolio
0.03%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $4,259 - $5,182
-26 Reduced 10.57%
220 $43.4 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $1,702 - $1,988
-11 Reduced 4.28%
246 $42.2 Million
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $1,758 - $2,003
11 Added 4.47%
257 $46.8 Million
Q4 2023

Apr 03, 2024

BUY
$137.6 - $154.97 $33,849 - $38,122
246 New
246 $38.1 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wealth Collab, LLC Portfolio

Follow Wealth Collab, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Collab, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Collab, LLC with notifications on news.